• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Illustration of stacked gold coins with a hand placing another coin on top set against an upward-trending red arrow and stoc
Special Reports

Big Pharma's 10 highest-paid CEOs of 2025

Fierce is finishing the 2025 tally by laying out the annual rankings of the top-paid CEOs among the industry's heavyweight companies.
Fraiser Kansteiner , Kevin Dunleavy , Zoey Becker , Eric Sagonowsky Jun 16, 2026 3:00am
Beyond China and Japan How biopharma is expanding rare disease access across Asia-Pacific

Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific

Brought to you by DKSH
China flag against blue sky

CARsgen's gastric cancer CAR-T nabs world-first China approval

Jun 22, 2026 12:31pm
The legacy approach to real-world data is costing you

The legacy approach to real-world data is costing you

Brought to you by HealthVerity
Germany German pharma Germany pharma German flag

US puts German drug spending reform proposals under microscope

Jun 22, 2026 10:14am
showdown clash versus vs crash lightning fight dispute

Alnylam scolded over promotional activity after Pfizer complaint

Jun 22, 2026 9:46am
More News
Fierce Biotech

A 5-month sprint: Inside Pfizer's $10B deal with Innovent

Jun 21, 2026 10:41pm

Aurobindo must divest 4 drugs to complete Lannett buyout: FTC

Jun 18, 2026 3:45pm

Regulatory tracker: FDA approves expansion for Merck's Capvaxive

Jun 18, 2026 2:15pm

Pfizer's CFO Dave Denton plans August departure

Jun 18, 2026 11:50am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings